Effect of Dexamethasone on Reduction of Macular Thickness in Diabetic Patients, a Randomized Clinical Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 1, 2016

Primary Completion Date

December 20, 2017

Study Completion Date

October 5, 2018

Conditions
Diabetic Macular Edema
Interventions
DRUG

Intravitreous Dexamethasone Solution 4mg/ml - vol 0,01 ml

0,01 ml intravitreous dexamethasone solution 4mg/ml injection.

DRUG

Intravitreous Dexamethasone Solution 4mg/ml - vol 0,03 ml

0,03 ml intravitreous dexamethasone solution 4mg/ml injection.

DRUG

Intravitreous Dexamethasone Solution 4mg/ml - vol 0,05 ml

0,05 ml intravitreous dexamethasone solution 4mg/ml injection.

Trial Locations (1)

13083887

State University of Campinas, Campinas

All Listed Sponsors
lead

Universidade Federal de Pernambuco

OTHER

NCT03608839 - Effect of Dexamethasone on Reduction of Macular Thickness in Diabetic Patients, a Randomized Clinical Trial | Biotech Hunter | Biotech Hunter